125 related articles for article (PubMed ID: 11251868)
1. Cost analysis: concepts and application.
Brosnan CA; Swint JM
Public Health Nurs; 2001; 18(1):13-8. PubMed ID: 11251868
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the cost of neonatal screening for congenital adrenal hyperplasia.
Brosnan CA; Brosnan PG; Swint JM
Pediatrics; 2001 May; 107(5):1238. PubMed ID: 11388323
[No Abstract] [Full Text] [Related]
3. The cost effectiveness of screening newborns for congenital adrenal hyperplasia.
Yoo BK; Grosse SD
Public Health Genomics; 2009; 12(2):67-72. PubMed ID: 19039250
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neonatal screening for congenital adrenal hyperplasia.
Honour JW; Torresani T
Horm Res; 2001; 55(4):206-11. PubMed ID: 11598376
[TBL] [Abstract][Full Text] [Related]
5. Improving neonatal screening for congenital adrenal hyperplasia.
Speiser PW
J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
[No Abstract] [Full Text] [Related]
6. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
Grosse SD; Thompson JD; Ding Y; Glass M
Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Methods and Newborn Screening Assessment.
Castilla-Rodríguez I; Vallejo-Torres L; Couce ML; Valcárcel-Nazco C; Mar J; Serrano-Aguilar P
Adv Exp Med Biol; 2017; 1031():267-281. PubMed ID: 29214578
[TBL] [Abstract][Full Text] [Related]
8. [Programs of systematic screening in neonatology. Pharmaco-economic aspects].
Schoos R; Verloes A; Bourguignon JP; Koulischer L
Rev Med Liege; 1998 May; 53(5):311-5. PubMed ID: 9689890
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness methods of newborn screening assessment.].
Valcárcel Nazco C; García Pérez L; Linertová R; Castilla I; Vallejo Torres L; Ramos Goñi JM; Labrador Cañadas V; Couce ML; Espada Sáenz-Torres M; Dulín Íñiguez E; Posada M; Imaz Iglesia I; Serrano Aguilar P
Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496278
[TBL] [Abstract][Full Text] [Related]
10. Potential costs and benefits of newborn screening for severe combined immunodeficiency.
McGhee SA; Stiehm ER; McCabe ER
J Pediatr; 2005 Nov; 147(5):603-8. PubMed ID: 16291349
[TBL] [Abstract][Full Text] [Related]
11. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland.
Autti-Rämö I; Mäkelä M; Sintonen H; Koskinen H; Laajalahti L; Halila R; Kääriäinen H; Lapatto R; Näntö-Salonen K; Pulkki K; Renlund M; Salo M; Tyni T
Acta Paediatr; 2005 Aug; 94(8):1126-36. PubMed ID: 16188860
[TBL] [Abstract][Full Text] [Related]
12. The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States.
Rothschild MI; Russ R; Brennan KA; Williams CJ; Berrones D; Patel B; Martinez-Castellanos MA; Fernandes A; Hubbard GB; Chan RVP; Yang Z; Olsen TW
Am J Ophthalmol; 2016 Aug; 168():110-121. PubMed ID: 27130372
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive cost-utility analysis of newborn screening strategies.
Carroll AE; Downs SM
Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
[TBL] [Abstract][Full Text] [Related]
14. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
15. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
[TBL] [Abstract][Full Text] [Related]
17. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
18. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
Brosnan CA; Brosnan P; Therrell BL; Slater CH; Swint JM; Annegers JF; Riley WJ
Public Health Rep; 1998; 113(2):170-8. PubMed ID: 9719819
[TBL] [Abstract][Full Text] [Related]
19. "The Newborn Screening Saves Lives Act"--four million calls for support!
Rivkees SA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):457-8. PubMed ID: 17550207
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of newborn screening for severe combined immunodeficiency.
Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME
Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
